Dr. Lee Chooi Yeng

.

Senior Lecturer
School of Pharmacy

chooi.yeng.lee@monash.edu
+603 5514 6314
Room  2-5-13

Dr Lee obtained her PhD in pharmacology and physiology from Universiti Malaya, and subsequently underwent postdoctoral training at the University of Shizuoka, Japan under the sponsorship of the Japan Global COE Program.

She joined the Pharmacy program of the School of Medicine and Health Sciences, Monash University Malaysia in Nov 2009, and is currently Senior Lecturer of the School of Pharmacy, Monash University Malaysia. Dr Lee is one of the pioneer members of staff of the School of Pharmacy who has contributed significantly in various aspects in the progress of the School, including the establishment of the School of Pharmacy.

Her current primary research interests include utilising innovative educational technologies to improve students engagement as well as learning effectiveness of pharmacology and pharmacotherapy, and also discipline-based research specifically mechanisms that contribute to the development and manifestation of obesity, and identifying novel treatment options for obesity.

Dr Lee’s research has been supported by various internal and external competitive grants where she was the principal investigator. Her focus on quality education and research as well as her commitment to teaching has led her to publish in high impact journals and the receipt of numerous teaching and education excellence awards.

Qualifications

- Doctor of Philosophy (PhD), Universiti Malaya, 2008

Expertise

- Pharmacy Education

- Obesity

- Drug Delivery

Awards and Honours

2019

  • Long Service Award, Monash University Malaysia

2018

  • Monash University Vice Chancellor Award for Teaching Excellence (Team Award)
  • Monash University Faculty of Pharmacy and Pharmaceutical Sciences Dean's Teaching Excellence Award (Team Award)

2017

  • Monash University Malaysia Pro-Vice Chancellor Award for Excellence in Education (Individual Award)
  • Best Oral Presentation Award at the 3rd International Conference on Frontiers of Educational Technologies, held at the Imperial College, London, UK

No content

Peer - reviewed Journal

Brock T, Vu T, Kadirvelu A, Lee CY, Kent F (2020). Implementing a collaborative medicine and pharmacy educational activity in two countries. Medical Education Online 25: 1-8.

Lee CY (2020). How to improve the effectiveness of blended learning of pharmacology and pharmacotherapy? A case study in pharmacy program. Technology, Knowledge and Learning, https://doi.org/10.1007/s10758-020-09447-5

Shaikh MF, Lee CY, Chen WN, Shaikh FA (2020). The gut-brain-axis on the manifestation of depressive symptoms in epilepsy: An evidence-driven hypothesis. Frontiers in Pharmacology 11: 465.

Lee CY, Li SY, Li XF, Stalker DAE, Cooke C, Shao B, Kelestimur H, Henry BA, Conductier G, O’Byrne K, Clarke IJ (2019). Lipopolysaccharide reduces gonadotrophin-releasing hormone (GnRH) gene expression: role of RFamide-related peptide-3 and kisspeptin. Reproduction, Fertility and Development 31: 1134-1143.

Zaman R, Islam RA, Ibnat N, Othman I, Zaini A, Lee CY, Chowdhury EH (2019). Current strategies in extending half-lives of therapeutic proteins. Journal of Controlled Release 301: 176-189.

Lee CY, White PJ, Malone DT (2018). Online educational games improve the learning of cardiac pharmacology in undergraduate pharmacy teaching. Pharmacy Education 18: 298-302.

Lee CY, Sen A (2018). Students Voice in their Learning: Incorporating Students’ Expectations in Learning Design of E-learning of Pharmacotherapy. International Journal of Learning and Teaching 4: 203-208.

Chia YL, Sen A, Tha KK, Lee CY (2017). An effective e-learning module for gastrointestinal disease pharmacology. INTED 2017 Proceedings, pages 1572-1580. ISBN: 978-84-617-8491-2. doi: 10.21125/inted.2017.0500

Lee CY (2017). Strategies of temozolomide in future glioblastoma treatment. OncoTargets and Therapy 10: 265-270.

Lee CY, Ooi IH (2016). Preparation of Temozolomide-loaded nanoparticles for glioblastoma multiforme targeting – ideal versus reality. Pharmaceuticals 9: 54(3). doi:10.3390/ph9030054

Lee CY (2016). Glucagon-like peptide-1 formulation – the present and future development in diabetes treatment. Basic & Clinical Pharmacology & Toxicology 118: 173-180.

Principle Investigator for National and International grants

Monash Warwick Alliance
Title of Research: Development and evaluation of augmented reality/virtual reality technologies in the teaching of cardiovascular disease
Duration: 2018 - 2021
Amount: AUD 38,244

Monash University
Title of Research: Development and evaluation of an interactive e-learning module for active learning of gastrointestinal diseases pharmacotherapy
Duration: 2016 - 2017
Amount: RM 40,000

Ministry of Education Malaysia
Title of Research: Suppressing appetite and body weight gain through delivery of glucagon-like peptide-1 (GLP1) to the brain using novel GLP1-loaded pH-sensitive inorganic nanoparticles.
Duration: 2014 - 2016
Amount: RM 120,000

No content

Membership in International Bodies

Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)

Member

Editorial Board Member

Journal of Digestive Diseases and Hepatology

Conference Organising/Technical Committee

International Conference on Frontiers of Educational Technologies (ICFET), 2018-2020.

Reviewer

Advances in Health Sciences Education, The American Journal of Pharmaceutical Education, Pharmacy, Pharmacy Education, Clinical Pharmacokinetics, Clinical and Experimental Pharmacology and Physiology.